Navigation Links
One-year results from Horizons-AMI trial reported at TCT 2009
Date:9/21/2009

SAN FRANCISCO, CA SEPTEMBER 21, 2009 Two subset analyses from the landmark HORIZONS-AMI trial show that the anticoagulant bivalirudin lowers major bleeding and cardiac death versus the combination of heparin and a GP IIb/IIIa inhibitor in patients with ST-segment myocardial infarction (STEMI) who have disease of the left anterior descending artery (LAD), while in STEMI patients at highest risk for death, bivalirudin also confers the greatest mortality benefit.

Two teams of European researchers will report on one-year results from these two substudies at the 21st annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF). Both will be presented as poster abstracts (TCT-306 and TCT-304) on Tuesday, September 22 between 8:00 a.m. and 10:00 a.m. in Hall D of The Moscone Center.

The landmark HORIZONS-AMI trial, sponsored by CRF, is expected to significantly impact the way that patients are treated. Two-year data from the trial will also be presented as a Late Breaking Trial on Friday, September 25 at TCT.

The two abstracts examine additional important information regarding outcomes of patients with acute myocardial infarction (AMI). One of the substudies focuses on primary angioplasty in acute anterior myocardial infarction with bivalirudin compared to unfractionated heparin plus GpIIb/IIIa inhibitors. This includes patients with massive heart attacks and the effect of pharmacotherapy in these patients. The other substudy examines the benefits of bivalirudin therapy in the highest risk patients who present with a heart attack.

A research team lead by Jochen Whrle, MD, University of Ulm (Ulm, Germany) looked at clinical outcomes in patients with ST segment elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI) of left anterior descending (LAD) coronary artery disease compared to non-LAD lesions. Investigators evaluate
'/>"/>

Contact: Judy Romero
jromero@crf.org
347-407-2774
Cardiovascular Research Foundation
Source:Eurekalert

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. 132 Members of Congress Urge One-Year Delay in Controversial Medicare Bidding Program for Home Medical Equipment
2. INVEGA(TM) Shows Favorable Long-Term Safety Profile in a One-Year Study of Patients With Schizophrenia
3. New type of sirolimus-eluting stent demonstrates superior results
4. Details Emerge About Approach, Results of First US Face Transplant
5. Instrumentation Laboratory Announces Passion & Results Award Winners
6. Bioniche Reports Fiscal 2009 Year-End Results
7. Results of Ongoing Testing Show Air Quality is Safe Near Schools in Beaver and Erie Counties in Pennsylvania
8. Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results
9. PRO-DEX, INC. Announces Fiscal 2009 Fourth Quarter and Full-year Results
10. Immucor to Announce Fiscal First Quarter Financial Results on Thursday, October 1, 2009
11. Neogen Corporation Announces 1st Quarter Results Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... that no direct link has been found, , , WEDNESDAY, ... food -- commonly linked to food poisoning and the ... be the cause of some urinary tract infections. , ... in chicken from stores and restaurants and in women ... the germs were transmitted directly to the women through ...
(Date:12/16/2009)... of children are uninsured, government report finds , , WEDNESDAY, ... months of this year, 45.4 million Americans of all ... had no health insurance, according to new National Health ... million (19.4 percent) people of all ages had been ... to the interview, and 31.9 million (10.6 percent) had ...
(Date:12/16/2009)... NEW ORLEANS, Dec. 16 A new software ... takes for inpatient healthcare facilities to calculate their staffing ... 24/7 Staffing Census allows inpatient healthcare facilities to ... state,s patient-per-day (PPD) ratios and receive a daily report ... ,, CareRise, a leader in risk management in ...
(Date:12/16/2009)... shrouded man found in a tomb on the edge of ... case of leprosy. Details of the research will be published ... The molecular investigation was undertaken by Prof. Mark Spigelman and ... for the Study of Infectious and Tropical Diseases at the ... Vernon of Lakehead University, Canada, Prof. Azriel Gorski of New ...
(Date:12/16/2009)... that wellness programs have a positive impact on employee presenteeism ... ... Minneapolis, MN (PRWEB) December 16, 2009 -- A recent survey ... have improved employee participation in health and wellness programs by ... by Hallmark Insights, a leader in incentive-driven health and wellness ...
Breaking Medicine News(10 mins):Health News:Foodborne E. Coli Suspected in Urinary Tract Infections 2Health News:Foodborne E. Coli Suspected in Urinary Tract Infections 3Health News:Over 45 Million Americans Now Lack Health Insurance 2Health News:United States Patent Office Allows CareRise Patent on 24/7 Staff-Census Software 2Health News:DNA of Jesus-era shrouded man in Jerusalem reveals earliest case of leprosy 2Health News:DNA of Jesus-era shrouded man in Jerusalem reveals earliest case of leprosy 3Health News:Hallmark Insights' Employer Survey Reveals Cost-Savings Benefits of Health & Wellness Programs 2
... and nutrition researcher Frank,Ervolino, ND, investigated a product ... associated with stimulants. He reports that,Appetite Down ( ... novel use of an established ingredient with,promising results., ... weight. In fact, in the,U.S., where the CDC ...
... of Warwick, Dartmouth College, and the University of Leuven, ... the weight of those around them. Without being aware ... with the weight of the Joneses. For a whole ... obesity. The researchers will present their results on Friday ...
... of interoperable Health Information Technology (HIT) will be ... the U.S. healthcare system," Yul D. Ejnes, MD, FACP, ... Health today. "Unfortunately, without adequate financial incentives, small ... technological curve." Dr. Ejnes, a member of the Board ...
... Educators launches first of three-part series, MONTCLAIR, N.J., ... announces the launch of an educational Webcast series on,chronic ... and chronic pain sufferer, Nikki Stone. The first in ... to,Hold You Back" is available today at http://www.painawareness.org ...
... Colombia has appointed Dallas sports,chiropractor, Dr. Camille Reagan ... the upcoming Olympic Games in Beijing. Dr. Reagan has ... the Costa,Rican team for the 2007 Pan American Games ... to bring the profession to an international sports,platform," said ...
... 24 Palomar Medical,Technologies, Inc. (Nasdaq: PMTI ), ... removal and other cosmetic treatments, will,hold its quarterly conference ... July 31, 2008 at 11:30AM Eastern Time. If you ... AM Eastern Time on,that day. The telephone replay will ...
Other Medicine News:Health News:New Natural Product from Zurich Pharmaceuticals Downs Appetite 2Health News:Research says fat friends and poor education helps people think thin 2Health News:ACP says Medicare should increase payments for physicians that use HIT to improve quality 2Health News:Video: Olympic Games Gold Medalist Nikki Stone Joins Chronic Pain Experts in Educational Webcasts 2Health News:Video: Olympic Games Gold Medalist Nikki Stone Joins Chronic Pain Experts in Educational Webcasts 3Health News:Video: Olympic Games Gold Medalist Nikki Stone Joins Chronic Pain Experts in Educational Webcasts 4Health News:Video: Olympic Games Gold Medalist Nikki Stone Joins Chronic Pain Experts in Educational Webcasts 5Health News:Video: Olympic Games Gold Medalist Nikki Stone Joins Chronic Pain Experts in Educational Webcasts 6Health News:Video: Olympic Games Gold Medalist Nikki Stone Joins Chronic Pain Experts in Educational Webcasts 7Health News:Colombia Appoints Dallas Chiropractor to Olympic Team 2Health News:Palomar Medical Technologies to Host Second Quarter 2008 Financial Results Conference Call and Webcast on July 31, 2008 2
(Date:12/16/2009)... Dec. 16 CareCentrix, Inc ., ... management services, announced today that it has been ... DC-based health care accrediting organization that establishes quality ... guarantee that only appropriately trained, qualified clinical personnel ... a reasonable and timely appeals process is in ...
(Date:12/16/2009)... December 16 Biovista Inc.,today announced that ... Award,in Healthcare, at the 2009 New England Venture ... award, which recognizes cutting edge private companies,driving the ... competed with,over 50 other privately held companies that ... Life Sciences and Clean-tech sectors. , ...
(Date:12/16/2009)... ANN ARBOR, Mich., Dec. 16 GlaxoSmithKline ... NanoBio Corporation today announced an exclusive licensing agreement ... over-the-counter (OTC) use of NB-001, a novel, patented ... of cold sores. Developed by NanoBio, NB-001 provides ... cold sores, herpes labialis . ,, ...
Breaking Medicine Technology:CareCentrix Receives URAC Health Utilization Management Accreditation 2Biovista Inc. Named Top Innovator in Life Sciences 2GlaxoSmithKline and NanoBio Announce OTC Licensing Agreement for Cold Sore Treatment 210 students receive scholarships for outstanding work in public health systems research 50092 1Cells use import machinery to export their goods as well 9010 1Cells use import machinery to export their goods as well 9010 2Cells use import machinery to export their goods as well 9010 3DuPont Adds Cotton to India Seed Product Lineup 12789 1DuPont Adds Cotton to India Seed Product Lineup 12789 2DuPont Adds Cotton to India Seed Product Lineup 12789 3DuPont Adds Cotton to India Seed Product Lineup 12789 4
... Panel at American Venous Forum Presents Clinical, ... Than Laser, SAN JOSE, Calif., Feb. 23 ... a worldwide leader in medical devices,for the minimally ... clinical performance data for the VNUS ClosureFAST(TM),catheter at ...
... WILMINGTON, Del., Feb. 21 DuPont (NYSE: ... Agricultural,Research Service (ARS) are teaming up to find new ... even in low concentrations, can cause severe illness., ... Meat,Animal Research Center (USMARC) at Clay Center, Neb., and ...
Other Medicine Technology:Study Data Shows VNUS ClosureFAST(TM) Catheter More than 96% Effective 2Study Data Shows VNUS ClosureFAST(TM) Catheter More than 96% Effective 3Study Data Shows VNUS ClosureFAST(TM) Catheter More than 96% Effective 4DuPont and USDA ARS to Collaborate on New E. coli Test in Beef 2
Angled upward 45 degrees for temporal approach. Open 14 mm blades....
Fenestrated 14 mm blades. Self-locking mechanism. Dull finish....
Infant model. Blades: 7 mm. Solid blades with locking mechanism. Dull finish....
Fenestrated 16 mm blades. Self-locking mechanism. Dull finish....
Medicine Products: